Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0501 | 0.315 | 0.315 |
Trypanosoma cruzi | 2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase, putative | 0.013 | 0.0471 | 0.0172 |
Trypanosoma brucei | beta lactamase | 0.0137 | 0.0521 | 0.0225 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0501 | 0.315 | 0.2933 |
Echinococcus granulosus | hexokinase | 0.1426 | 0.9825 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0501 | 0.315 | 0.315 |
Onchocerca volvulus | 0.0895 | 0.599 | 0.5971 | |
Plasmodium vivax | hexokinase, putative | 0.1426 | 0.9825 | 1 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0501 | 0.315 | 0.2987 |
Brugia malayi | Hexokinase family protein | 0.1426 | 0.9825 | 0.9825 |
Schistosoma mansoni | hypothetical protein | 0.0076 | 0.0079 | 0.0079 |
Leishmania major | glucose-6-phosphate 1-dehydrogenase, putative | 0.1028 | 0.6947 | 0.6977 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0501 | 0.315 | 0.3151 |
Trichomonas vaginalis | Citrate lyase beta chain, putative | 0.013 | 0.0471 | 0.0169 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0501 | 0.315 | 0.2933 |
Echinococcus multilocularis | caspase | 0.0401 | 0.2427 | 0.2471 |
Loa Loa (eye worm) | hexokinase | 0.1426 | 0.9825 | 0.9825 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0107 | 0.0307 | 0.0307 |
Echinococcus multilocularis | caspase 2 | 0.0107 | 0.0307 | 0.0312 |
Plasmodium vivax | glucose-6-phosphate 1-dehydrogenase, putative | 0.1072 | 0.7265 | 0.7311 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0501 | 0.315 | 0.2933 |
Schistosoma mansoni | glucose-6-phosphate 1-dehydrogenase | 0.1028 | 0.6947 | 0.6947 |
Schistosoma mansoni | hexokinase | 0.1426 | 0.9825 | 0.9825 |
Trypanosoma cruzi | 2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase, putative | 0.013 | 0.0471 | 0.0172 |
Trichomonas vaginalis | glutaminase, putative | 0.1451 | 1 | 1 |
Mycobacterium tuberculosis | Probable glucose-6-phosphate 1-dehydrogenase Zwf2 (G6PD) | 0.0356 | 0.2105 | 1 |
Leishmania major | hexokinase, putative | 0.1426 | 0.9825 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0501 | 0.315 | 0.2987 |
Onchocerca volvulus | Hexokinase homolog | 0.0895 | 0.599 | 0.5971 |
Onchocerca volvulus | 0.1426 | 0.9825 | 1 | |
Trypanosoma cruzi | glucose-6-phosphate 1-dehydrogenase, putative | 0.1028 | 0.6947 | 0.6977 |
Loa Loa (eye worm) | glutaminase 2 | 0.1451 | 1 | 1 |
Schistosoma mansoni | subfamily C14A unassigned peptidase (C14 family) | 0.0107 | 0.0307 | 0.0307 |
Schistosoma mansoni | caspase-3 (C14 family) | 0.0401 | 0.2427 | 0.2427 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0076 | 0.0079 | 0.008 |
Schistosoma mansoni | glutaminase | 0.1451 | 1 | 1 |
Trypanosoma cruzi | glucose-6-phosphate 1-dehydrogenase, putative | 0.034 | 0.199 | 0.1768 |
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 0.0307 | 0.0307 |
Mycobacterium ulcerans | lipoprotein LpqF | 0.0137 | 0.0521 | 0.0053 |
Loa Loa (eye worm) | hexokinase | 0.1426 | 0.9825 | 0.9825 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0076 | 0.0079 | 0.0079 |
Loa Loa (eye worm) | hexokinase | 0.0895 | 0.599 | 0.599 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0076 | 0.0079 | 0.008 |
Loa Loa (eye worm) | hypothetical protein | 0.0453 | 0.2805 | 0.2805 |
Toxoplasma gondii | glucose-6-phosphate 1-dehydrogenase | 0.0671 | 0.4375 | 0.4274 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.1129 | 0.7679 | 0.7745 |
Brugia malayi | Hexokinase family protein | 0.0441 | 0.2718 | 0.2718 |
Brugia malayi | hexokinase | 0.1426 | 0.9825 | 0.9825 |
Echinococcus granulosus | hexokinase | 0.1426 | 0.9825 | 1 |
Echinococcus multilocularis | hexokinase | 0.1426 | 0.9825 | 1 |
Onchocerca volvulus | 0.1426 | 0.9825 | 1 | |
Trichomonas vaginalis | glucosamine-6-phosphate isomerase, putative | 0.1072 | 0.7265 | 0.7179 |
Entamoeba histolytica | hexokinase 2 | 0.1426 | 0.9825 | 1 |
Mycobacterium tuberculosis | Probable conserved lipoprotein LpqF | 0.0137 | 0.0521 | 0.0308 |
Brugia malayi | glucose-6-phosphate dehydrogenase | 0.1028 | 0.6947 | 0.6947 |
Trypanosoma cruzi | Glucose-6-phosphate dehydrogenase, putative | 0.0331 | 0.1919 | 0.1693 |
Trypanosoma cruzi | hexokinase, putative | 0.1426 | 0.9825 | 1 |
Schistosoma mansoni | kinase | 0.0255 | 0.1371 | 0.1371 |
Loa Loa (eye worm) | hypothetical protein | 0.0453 | 0.2805 | 0.2805 |
Loa Loa (eye worm) | hexokinase type II | 0.1426 | 0.9825 | 0.9825 |
Echinococcus granulosus | caspase 3 apoptosis cysteine peptidase | 0.0401 | 0.2427 | 0.2471 |
Mycobacterium leprae | PROBABLE CONSERVED LIPOPROTEIN LPQF | 0.0137 | 0.0521 | 0.5 |
Mycobacterium ulcerans | glutaminase | 0.1451 | 1 | 1 |
Brugia malayi | Hexokinase family protein | 0.0895 | 0.599 | 0.599 |
Brugia malayi | Cell death protein 3 precursor | 0.0107 | 0.0307 | 0.0307 |
Trypanosoma brucei | hexokinase | 0.1426 | 0.9825 | 1 |
Echinococcus multilocularis | hexokinase | 0.1426 | 0.9825 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0501 | 0.315 | 0.2933 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0501 | 0.315 | 0.2933 |
Leishmania major | hypothetical protein, conserved | 0.1129 | 0.7679 | 0.7745 |
Trypanosoma cruzi | hexokinase, putative | 0.1426 | 0.9825 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0501 | 0.315 | 0.2933 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0501 | 0.315 | 0.2987 |
Loa Loa (eye worm) | glutaminase | 0.1451 | 1 | 1 |
Plasmodium falciparum | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0.1072 | 0.7265 | 0.7311 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0501 | 0.315 | 0.315 |
Trypanosoma brucei | glucose-6-phosphate 1-dehydrogenase | 0.1028 | 0.6947 | 0.6977 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0511 | 0.3217 | 0.3217 |
Loa Loa (eye worm) | hypothetical protein | 0.0973 | 0.6553 | 0.6553 |
Entamoeba histolytica | hexokinase 1 | 0.1426 | 0.9825 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.1129 | 0.7679 | 0.7745 |
Echinococcus multilocularis | caspase 3 | 0.0294 | 0.1653 | 0.1683 |
Mycobacterium ulcerans | glucose-6-phosphate 1-dehydrogenase | 0.0671 | 0.4375 | 0.4097 |
Echinococcus granulosus | caspase 3 | 0.0294 | 0.1653 | 0.1683 |
Loa Loa (eye worm) | glucose-6-phosphate dehydrogenase | 0.1028 | 0.6947 | 0.6947 |
Plasmodium falciparum | hexokinase | 0.1426 | 0.9825 | 1 |
Mycobacterium tuberculosis | Class a beta-lactamase BlaC | 0.0285 | 0.1592 | 0.6861 |
Brugia malayi | MH2 domain containing protein | 0.0511 | 0.3217 | 0.3217 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0501 | 0.315 | 0.3206 |
Echinococcus multilocularis | caspase 8 | 0.0107 | 0.0307 | 0.0312 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0248 | 0.1323 | 0.1049 |
Trypanosoma brucei | hexokinase | 0.1426 | 0.9825 | 1 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0401 | 0.2427 | 0.2427 |
Echinococcus granulosus | caspase 2 | 0.0107 | 0.0307 | 0.0312 |
Giardia lamblia | Glucose-6-phosphate 1-dehydrogenase | 0.1072 | 0.7265 | 1 |
Echinococcus multilocularis | glucose 6 phosphate 1 dehydrogenase | 0.1028 | 0.6947 | 0.7071 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0501 | 0.315 | 0.2987 |
Echinococcus granulosus | hexokinase | 0.1426 | 0.9825 | 1 |
Echinococcus granulosus | glucose 6 phosphate 1 dehydrogenase | 0.1028 | 0.6947 | 0.7071 |
Echinococcus multilocularis | citrate lyase subunit beta protein | 0.013 | 0.0471 | 0.0479 |
Brugia malayi | hexokinase type II | 0.0453 | 0.2805 | 0.2805 |
Trypanosoma brucei | hexokinase, putative | 0.1426 | 0.9825 | 1 |
Echinococcus granulosus | caspase | 0.0401 | 0.2427 | 0.2471 |
Trichomonas vaginalis | 6-phosphogluconolactonase, putative | 0.1072 | 0.7265 | 0.7179 |
Echinococcus granulosus | caspase 8 | 0.0107 | 0.0307 | 0.0312 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.1129 | 0.7679 | 0.7745 |
Echinococcus granulosus | citrate lyase subunit beta protein | 0.013 | 0.0471 | 0.0479 |
Trichomonas vaginalis | glucosamine-6-phosphate isomerase, putative | 0.1072 | 0.7265 | 0.7179 |
Leishmania major | 2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase, putative | 0.013 | 0.0471 | 0.0172 |
Echinococcus multilocularis | caspase 3, apoptosis cysteine peptidase | 0.0401 | 0.2427 | 0.2471 |
Echinococcus multilocularis | hexokinase type 2 | 0.1426 | 0.9825 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 0.0307 | 0.0307 |
Toxoplasma gondii | hexokinase | 0.1426 | 0.9825 | 1 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0501 | 0.315 | 0.3206 |
Mycobacterium ulcerans | glucose-6-phosphate 1-dehydrogenase | 0.1028 | 0.6947 | 0.6797 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0501 | 0.315 | 0.2933 |
Mycobacterium ulcerans | class a beta-lactamase, BlaC | 0.0285 | 0.1592 | 0.1177 |
Treponema pallidum | hexokinase (hxk) | 0.1426 | 0.9825 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0248 | 0.1323 | 0.1049 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0511 | 0.3217 | 0.3217 |
Onchocerca volvulus | 0.1426 | 0.9825 | 1 | |
Toxoplasma gondii | glucose-6-phosphate 1-dehydrogenase | 0.1072 | 0.7265 | 0.7311 |
Loa Loa (eye worm) | hexokinase | 0.0441 | 0.2718 | 0.2718 |
Brugia malayi | hypothetical protein | 0.0076 | 0.0079 | 0.0079 |
Echinococcus granulosus | hexokinase type 2 | 0.1426 | 0.9825 | 1 |
Chlamydia trachomatis | glucose-6-phosphate 1-dehydrogenase | 0.1028 | 0.6947 | 0.5 |
Echinococcus multilocularis | hexokinase | 0.1426 | 0.9825 | 1 |
Brugia malayi | mucosa associated lymphoid tissue lymphoma translocation protein 1 | 0.0107 | 0.0307 | 0.0307 |
Trypanosoma brucei | polo-like protein kinase | 0.0501 | 0.315 | 0.2987 |
Leishmania major | hexokinase, putative | 0.1426 | 0.9825 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.